AUTHOR=Tashireva Liubov A. , Zavyalova Marina V. , Savelieva Olga E. , Gerashchenko Tatyana S. , Kaigorodova Evgeniya V. , Denisov Evgeny V. , Perelmuter Vladimir M. 

TITLE=Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis

JOURNAL=Frontiers in Oncology

VOLUME=10

YEAR=2020

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00050

DOI=10.3389/fonc.2020.00050

ISSN=2234-943X

ABSTRACT=<p><bold>Introduction:</bold> The identification of tumor cells that can be potential metastatic seeds would reach two key aims—prognosis of metastasis risk and appointment of the optimal adjuvant therapy to prevent metastatic disease. Single tumor cells (STCs) located out of multicellular structures can most likely demonstrate features that are needed to initiate metastasis.</p><p><bold>Methods:</bold> One-hundred-and-thirty-five patients with invasive breast carcinoma of no special type have been enrolled. Molecular subtypes of breast cancer were categorized according to St. Gallen recommendations. Hematoxylin and eosin staining was used to identify STCs with epithelial-like morphology (eSTCs) in breast tumors. Immunofluorescence staining was applied to evaluate stemness and epithelial–mesenchymal transition (EMT) in STCs. The correlation between STCs and recurrence and metastasis-free survival (MFS) was performed using the Kaplan–Meier method and the log-rank test.</p><p><bold>Results:</bold> Distant metastasis was more frequent in eSTC-positive than eSTC-negative patients (28.0% vs. 9.4%, <italic>p</italic> = 0.007). When tumor types were analyzed separately, distant metastasis tended to be more frequent in eSTC-positive than eSTC-negative patients for HER2-positive cancer [75.0% (3/4) vs. 12.5% (1/8), <italic>p</italic> = 0.066]. In luminal A [22.7% (5/22) vs. 10.0% (3/30), <italic>p</italic> = 0.259], luminal B [21.1% (4/19) vs. 6.7% (2/30), <italic>p</italic> = 0.189], and triple-negative [40.0% (2/5) vs. 11.8% (2/17), <italic>p</italic> = 0.209] cancers, distance metastasis was not associated with eSTCs. Median MFS was not reached in eSTC-positive and eSTC-negative patients. eSTC-positive patients had a higher risk of breast cancer metastasis [hazard ratio (HR) 3.57, 95% confidence interval (CI): 1.46–8.71; <italic>p</italic> = 0.001]. When tumor types were analyzed separately, a higher risk of breast cancer metastasis occurred only in HER2-positive patients (HR 8.49, 95% CI: 1.29–55.59; <italic>p</italic> = 0.016). Immunofluorescence analysis revealed mesenchymal-like STCs (mSTCs) and inter- and intra-tumor heterogeneity in STCs. There were breast tumors with either eSTCs or mSTCs and tumors with both types of STCs. Both eSTCs and mSTCs were represented by cells with different stem and/or EMT phenotypes.</p><p><bold>Conclusions:</bold> STCs with epithelial-like morphology contribute to breast cancer metastasis and represent an attractive model for studying mechanisms of metastatic seeding. The assessment of STCs in histological sections of breast tumors can be a simple and effective method for the prediction of metastasis risk.</p>